Metastat Inc (MTST) Financial Statements (2024 and earlier)
Company Profile
Business Address |
27 DRYDOCK AVE., 2ND FLOOR BOSTON, MA 02210 |
State of Incorp. | NV |
Fiscal Year End | February 28 |
Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
2/28/2018 | 2/28/2017 | 2/29/2016 | 2/28/2015 | 2/28/2014 | 2/28/2013 | |||
---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||
Current Assets | ||||||||
Cash, cash equivalents, and short-term investments | 782,707 | 363,783 | 257,820 | 483,408 | 969,188 | |||
Cash and cash equivalents | 782,707 | 363,783 | 257,820 | 483,408 | 969,188 | |||
Receivables | 125,000 | 20,000 | ||||||
Prepaid expense | 20,856 | 33,121 | 38,748 | ✕ | ||||
Deferred costs | 60,523 | |||||||
Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | 12,073 | |||
Total current assets: | 803,563 | 521,904 | 296,568 | 576,004 | 969,188 | |||
Noncurrent Assets | ||||||||
Property, plant and equipment | 414,635 | 497,052 | 526,606 | 204,254 | 53,326 | |||
Other undisclosed noncurrent assets | 43,600 | 43,600 | 278,952 | 10,367 | ||||
Total noncurrent assets: | 458,235 | 540,652 | 805,558 | 214,621 | 53,326 | |||
TOTAL ASSETS: | 1,261,798 | 1,062,556 | 1,102,126 | 790,625 | 1,022,514 | |||
LIABILITIES AND EQUITY | ||||||||
Liabilities | ||||||||
Current Liabilities | ||||||||
Accounts payable and accrued liabilities | 767,513 | 1,008,772 | 314,484 | 257,965 | 168,005 | |||
Interest and dividends payable | 15,638 | 48,317 | 16,767 | |||||
Accounts payable | 572,195 | 746,144 | 293,152 | 257,965 | 168,005 | |||
Accrued liabilities | 179,680 | 214,311 | 4,565 | |||||
Debt | 989,086 | 1,533,120 | 99,965 | 28,000 | ||||
Other undisclosed current liabilities | 193,407 | 56,000 | 2,351 | |||||
Total current liabilities: | 1,950,006 | 2,597,892 | 416,800 | 285,965 | 168,005 | |||
Noncurrent Liabilities | ||||||||
Long-term debt and lease obligation | 169,676 | |||||||
Capital lease obligations | 169,676 | |||||||
Liabilities, other than long-term debt | 2,106,972 | 234,461 | ||||||
Derivative instruments and hedges, liabilities | 2,106,972 | 234,461 | ||||||
Other undisclosed noncurrent liabilities | 273,000 | |||||||
Total noncurrent liabilities: | 2,106,972 | 234,461 | 442,676 | |||||
Other undisclosed liabilities | 2,585,418 | 718,897 | ||||||
Total liabilities: | 4,056,978 | 2,832,353 | 859,476 | 2,871,383 | 886,902 | |||
Equity | ||||||||
Equity, attributable to parent, including: | (2,795,180) | (1,769,797) | 242,650 | (2,080,758) | 135,612 | |||
Common stock | 471 | 185 | 2,747 | 2,157 | 2,106 | |||
Additional paid in capital | 23,523,140 | 21,607,259 | 18,962,965 | 8,644,760 | 5,495,985 | |||
Accumulated deficit | (26,318,885) | (23,377,328) | (18,723,149) | (10,727,675) | ||||
Other undisclosed equity, attributable to parent | 94 | 87 | 87 | (5,362,479) | ||||
Total equity: | (2,795,180) | (1,769,797) | 242,650 | (2,080,758) | 135,612 | |||
TOTAL LIABILITIES AND EQUITY: | 1,261,798 | 1,062,556 | 1,102,126 | 790,625 | 1,022,514 |
Income Statement (P&L) (USD)
2/28/2018 | 2/28/2017 | 2/29/2016 | 2/28/2015 | 2/28/2014 | 2/28/2013 | ||
---|---|---|---|---|---|---|---|
Revenues | 75,000 | 596 | |||||
Revenue, net | 75,000 | ||||||
Gross profit: | 75,000 | 596 | |||||
Operating expenses | (3,347,952) | (4,778,974) | (4,791,059) | (4,351,199) | (2,521,175) | ||
Other operating income (expense), net (Other Expenses) | 406,395 | 124,795 | (3,204,415) | 1,013,997 | |||
Operating loss: | (2,941,557) | (4,654,179) | (7,920,474) | (3,337,202) | (2,520,579) | ||
Nonoperating income | 2,483,227 | 71,543 | |||||
Debt instrument, convertible, beneficial conversion feature | 2,324,759 | 71,543 | |||||
Interest and debt expense | (1,375,829) | (317,238) | (104,245) | ||||
Loss from continuing operations: | (4,317,386) | (4,971,417) | (5,437,247) | (3,441,447) | (2,449,036) | ||
Loss before gain (loss) on sale of properties: | (4,317,386) | (4,971,417) | (5,437,247) | (3,441,447) | (2,449,036) | ||
Other undisclosed net income (loss) | 1,375,829 | 317,238 | (2,558,227) | (1,923,749) | (71,543) | ||
Net loss attributable to parent: | (2,941,557) | (4,654,179) | (7,995,474) | (5,365,196) | (2,520,579) | ||
Preferred stock dividends and other adjustments | 708,303 | 1,067,491 | 225,296 | ||||
Other undisclosed net loss available to common stockholders, basic | (3,984,321) | (2,402,040) | (467,359) | ||||
Net loss available to common stockholders, diluted: | (6,217,575) | (5,988,728) | (8,237,537) | (5,365,196) | (2,520,579) |
Comprehensive Income (USD)
2/28/2018 | 2/28/2017 | 2/29/2016 | 2/28/2015 | 2/28/2014 | 2/28/2013 | ||
---|---|---|---|---|---|---|---|
Net loss: | (2,941,557) | (4,654,179) | (7,995,474) | (5,365,196) | (2,520,579) | ||
Comprehensive loss, net of tax, attributable to parent: | (2,941,557) | (4,654,179) | (7,995,474) | (5,365,196) | (2,520,579) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.